申请人:Kolczewski Sabine
公开号:US20110190349A1
公开(公告)日:2011-08-04
The present invention relates to a compound of formula I
wherein
R
1
/R
2
are independently from each other hydrogen, (CR
2
)
o
-cycloalkyl, optionally substituted by lower alkyl or hydroxy, or are lower alkyl or heterocycloalkyl, and
o is 0 or 1; and
R may be the same or different and is hydrogen or lower alkyl; or
R
1
and R
2
may form together with the N atom to which they are attached a heterocycloalkyl group, selected from the group consisting of pyrrolidinyl, piperidinyl, 3-aza-bicyclo[3.1.0]hex-3-yl or 2-aza-bicyclo[3.1.0]hex-2-yl, which are optionally substituted by hydroxy;
R
3
is S-lower alkyl, lower alkyl, lower alkoxy or cycloalkyl;
R
3′
is hydrogen, lower alkyl substituted by halogen, lower alkyl or lower alkoxy
R
4
is lower alkyl substituted by halogen, lower alkyl or lower alkoxy;
X is —O— or —CH
2
—;
X′ is —O— or —CH
2
—; with the proviso that one of X or X′ is always —O— and the other is —CH
2
—;
or to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer thereof.
It has been found that the compounds of formula I are good inhibitors of the glycine transporter 1 (GlyT-1) and therefore they may be used for the treatment of schizophrenia.
本发明涉及一种化合物,其化学式为I,其中R1/R2独立地为氢、(CR2)o-环烷基,可选择地被较低的烷基或羟基取代,或者为较低的烷基或杂环烷基,o为0或1;而R可能相同也可能不同,为氢或较低的烷基;或者R1和R2可以与它们连接的N原子一起形成一个杂环烷基基团,选自吡咯烷基、哌啶基、3-氮杂双环[3.1.0]己基或2-氮杂双环[3.1.0]己基,可选择地被羟基取代;R3为S-较低的烷基、较低的烷基、较低的烷氧基或环烷基;R3'为氢、被卤素取代的较低的烷基、较低的烷基或较低的烷氧基;R4为被卤素取代的较低的烷基、较低的烷基或较低的烷氧基;X为—O—或—CH2—;X'为—O—或—CH2—;但其中X或X'中的一个始终为—O—,另一个为—CH2—;或者为药学上可接受的酸加合盐,为外消旋混合物,或为其对应的对映体和/或光学异构体。已发现,化合物I的抑制甘氨酸转运蛋白1(GlyT-1)的效果良好,因此可用于治疗精神分裂症。